The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 25, 2014

Filed:

Feb. 23, 2010
Applicants:

Stanislas Blein, La Chaux-de-Fonds, CH;

Darko Skegro, La Chaux-de-Fonds, CH;

Christophe Debonneville, La Chaux-de-Fonds, CH;

Martin Bertschinger, La Chaux-de-Fonds, CH;

Inventors:

Stanislas Blein, La Chaux-de-Fonds, CH;

Darko Skegro, La Chaux-de-Fonds, CH;

Christophe Debonneville, La Chaux-de-Fonds, CH;

Martin Bertschinger, La Chaux-de-Fonds, CH;

Assignee:

Glenmark Pharmaceuticals S.A., La Chaux-de-Fonds, CH;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61P 35/02 (2006.01); C07K 16/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to humanized antibodies or fragments thereof that bind to human CD19. More specifically, the present invention relates to a humanized antibody or fragment thereof that binds to human CD19 comprising a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 27, and/or a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 28, and/or a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 29; and/or comprising a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 30, and/or a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 31 and/or a light chain CDR3 comprising the amino acid sequence of SEQ ID NO: 32.


Find Patent Forward Citations

Loading…